English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/53182
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis

AuthorsTeruel, María; Simeón, Carmen P.; Broen, Jasper C.; Vonk, Madelon C.; Carreira, P.; Camps, M. T.; García-Portales, Rosa; Delgado-Frías, Esmeralda; Gallego, María; Espinosa, G.; Spanish Scleroderma Group; Beretta, L.; Airó, Paolo; Lunardi, C.; Riemekasten, G.; Witte, Torsten; Krieg, Thomas; Kreuter, A.; Distler, J. H.; Hunzelmann, Nicolas; Koeleman, B. P.; Voskuyl, Alexandre E.; Schuerwegh, A. J.; González-Gay, M. A.; Radstake, T. R.; Martín, J.
Issue Date25-Jun-2012
PublisherBioMed Central
CitationArthritis Research & Therapy 14(3) : R154- (2012)
AbstractAbstract Introduction The aim of the present study was to investigate the possible role of CD40 and CD40 ligand (CD40LG) genes in the susceptibility and phenotype expression of systemic sclerosis (SSc). Methods In total, 2,670 SSc patients and 3,245 healthy individuals from four European populations (Spain, Germany, The Netherlands, and Italy) were included in the study. Five single-nucleotide polymorphisms (SNPs) of CD40 (rs1883832, rs4810485, rs1535045) and CD40LG (rs3092952, rs3092920) were genotyped by using a predesigned TaqMan allele-discrimination assay technology. Meta-analysis was assessed to determine whether an association exists between the genetic variants and SSc or its main clinical subtypes. Results No evidence of association between CD40 and CD40LG genes variants and susceptibility to SSc was observed. Similarly, no significant statistical differences were observed when SSc patients were stratified by the clinical subtypes, the serologic features, and pulmonary fibrosis. Conclusions Our results do not suggest an important role of CD40 and CD40LG gene polymorphisms in the susceptibility to or clinical expression of SSc.
Appears in Collections:(IPBLN) Artículos
Files in This Item:
File Description SizeFormat 
ar3890.xml78,9 kBXMLView/Open
ar3890.pdf175,48 kBAdobe PDFThumbnail
AR3890-S1.DOC323 kBMicrosoft WordView/Open
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.